A RATIONAL APPROACH TO THE DEVELOPMENT OF ANTIVIRAL CHEMOTHERAPY: ALTERNATIVE SUBSTRATES OF HERPES SIMPLEX VIRUS TYPE 1 (HSV-1) AND TYPE 2 (HSV-2) THYMIDINE KINASE (TK)-Reference-Cited by-同舟云学术

A RATIONAL APPROACH TO THE DEVELOPMENT OF ANTIVIRAL CHEMOTHERAPY: ALTERNATIVE SUBSTRATES OF HERPES SIMPLEX VIRUS TYPE 1 (HSV-1) AND TYPE 2 (HSV-2) THYMIDINE KINASE (TK)

Published:1977-05 Issue:1 Third Confere Volume:284 Page:594-598
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann NY Acad Sci

Author:

Cheng Yung-Chi

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1977.tb21992.x/fullpdf

Reference12 articles.

1. HeLa cells resistant to bromodeoxyuridine and deficient in thymidine kinase activity

2. Mutant strains of herpes simplex deficient in thymidine kinase-inducing activity

3. Virus Type-Specific Thymidine Kinase in Cells Biochemically Transformed by Herpes Simplex Virus Types 1 and 2

4. Distinctive properties of thymidine kinase isozymes induced by human and avian herpesviruses

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative Structure–Activity Relationship in the Series of 5-Ethyluridine, N2-Guanine, and 6-Oxopurine Derivatives with Pronounced Anti-Herpetic Activity;Molecules;2023-11-22

2. A review: Mechanism of action of antiviral drugs;International Journal of Immunopathology and Pharmacology;2021-01

3. Specific Recognition of the Bicyclic Pyrimidine Nucleoside Analogs, a New Class of Highly Potent and Selective Inhibitors of Varicella-Zoster Virus (VZV), by the VZV-Encoded Thymidine Kinase;Molecular Pharmacology;2002-02-01

4. Nucleoside Analogues as Highly Potent and Selective Inhibitors of Herpes Simplex Virus Thymidine Kinase;Bioorganic & Medicinal Chemistry Letters;2001-07

5. Synthesis, biotransformation, pharmacokinetics, and antiviral properties of 5-ethyl-5-halo-6-methoxy-5,6-dihydro-2′-deoxyuridine diastereomers;Biochemical Pharmacology;1994-04